Our News on Newswise

Newswise: ViH_Cover_No-ToC_2019-03.jpg

Supplementary Measles Immunization Activities Provide More Equitable Results Than Routine Measles Immunization Programs

Value in Health announced new research showing that, across 20 low- and middle-income countries, supplementary measles immunization activities tended to provide more equitable vaccination delivery across socioeconomic groups than routine measles...
11-Aug-2020 6:35 AM EDT Add to Favorites

Newswise: ViH_Cover_No-ToC_2019-03.jpg

Coming of Age: Emerging Health Preference Research Based on Established Scientific Standards

Value in Health, the official journal of ISPOR, announced today the publication of a series of articles focused on recent developments in the field of health preference research.
10-Aug-2020 6:35 AM EDT Add to Favorites

Newswise: VOS_EiC_150x200_r1.jpg

New Editors-in-Chief Appointed for ISPOR’s Value & Outcomes Spotlight Magazine

ISPOR, the professional society for health economics and outcomes research (HEOR), announced the appointment of 2 new Editors-in-Chief for its HEOR news magazine, Value & Outcomes Spotlight.
4-Aug-2020 6:30 AM EDT Add to Favorites

Newswise: 001_Virtual-ISPOR-AP2020_150x200.jpg

ISPOR Announces Virtual ISPOR Asia Pacific 2020

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its Virtual ISPOR Asia Pacific 2020 event programming today. Registration is now open for the virtual event that will be held 14-16 September 2020.
3-Aug-2020 12:05 AM EDT Add to Favorites

Newswise: ViH_Cover_No-ToC_2019-03.jpg

ISPOR Working Group Provides a First-Ever Cross-Stakeholder Consensus Definition of “Patient Engagement in Research”

Value in Health announced the publication of results of an ISPOR systematic review and analysis resulting in a proposed definition of “patient engagement in research.”
7-Jul-2020 4:05 AM EDT Add to Favorites

Newswise: ISPOR-FDASummit_2020-06-19_150x200.jpg

ISPOR-FDA Summit 2020 on Patient-Preference Information in Medical Devices Is Now Virtual

ISPOR—the professional society for health economics and outcomes research, announced that its joint ISPOR-FDA Summit 2020 has been redesigned as a completely virtual event that will be held September 29, 2020.
22-Jun-2020 5:05 AM EDT Add to Favorites

Newswise: ViH_Cover_No-ToC_2019-03.jpg

Healthcare Time-Driven Activity-Based Costing Should Be Viewed as a Gold Standard

Value in Health announced today the publication of results of a study suggesting that time-driven activity-based costing can be an effective technique to support value-based healthcare initiatives.
17-Jun-2020 5:05 AM EDT Add to Favorites

Newswise: 2020-2021_Board_150x200.jpg

ISPOR Announces 2020-2021 Board of Directors

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the results of its recent elections and its 2020-2021 Board of Directors.
15-Jun-2020 4:05 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

About

ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.

ISPOR’s community of more than 20,000 individual and chapter members from 120+ countries includes a wide variety of health care stakeholders, including researchers, academicians, regulators and assessors, public and private payers, health care providers, industry, and patient representatives. The Society’s leadership has served as an unbiased resource and catalyst for innovation in the field for more than 20 years.

Contacts

Betsy Lane
Chief Marketing and Communications Officer

blane@ispor.org

609-586-4981 x 112

Emily Sinkiewicz
Manager, Marketing and Commumications

esinkiewicz@ispor.org

609-586-4981 x114

Twitter

close
0.57812